
Morgan Lewis
Former Governor of New York
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Sep 1, 2026
Turning the Tide on ATTR Matters
9:20
9:36
9:51
15:16

Carolyn WarfieldHOST
You mentioned earlier about the differences between wild-type and hereditary ATTR, and I'm hoping you could dive a little bit deeper into those variants and how many patients you see that are presented with each of those so we have a better understanding of those differences.

Morgan LewisGUEST
So understanding the different types can really help patients make sense of their own diagnosis.

Morgan LewisGUEST
In our program, I estimate that we see about 70% of our patients have wild type and roughly maybe about 25-30% have hereditary ATTR.
5 MINS LATER

Carolyn WarfieldHOST
From a population level perspective, how do the social determinants of health affect ATTR recognition, diagnosis, and treatments?